Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis
Authors:
Top Cited Papers
- 8 October 2024
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 25 (11) , 1413-1423
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (2U54CA143728-11)
- Centre International de Recherche sur le Cancer
- World Health Organization
- Institut National Du Cancer (INCa_14774)
This publication has 15 references indexed in Scilit:
- The global impact of tobacco control policies on smokeless tobacco use: a systematic reviewThe Lancet Global Health, 2023
- Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysisOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2023
- Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countriesThe Lancet Oncology, 2023
- The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019The Lancet, 2022
- Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019The Lancet Public Health, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysisClinical Oral Investigations, 2019
- Defining a global research and policy agenda for betel quid and areca nutThe Lancet Oncology, 2017
- Cancer and mortality among users and nonusers of snusInternational Journal of Cancer, 2008
- Global epidemiology of areca nut usageAddiction Biology, 2002